Stay updated on Eplontersen in ATTR CM: Clinical Trial
Sign up to get notified when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.

Latest updates to the Eplontersen in ATTR CM: Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element was removed.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%
- Check17 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as detailed drug information for Eplontersen. The revision number has also been updated to v3.0.0.SummaryDifference4%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.12, replacing the previous version v2.16.11. The phrasing regarding the last update has also changed from 'Estimated' to a definitive statement.SummaryDifference0.1%
- Check39 days agoChange DetectedThe page has been updated to reflect a reduction in the number of study locations from 144 to 142, and it now includes a new location, Azienda Ospedaliero Universitaria Delle Marche. Additionally, the last update date has been changed to August 8, 2025.SummaryDifference1%
- Check46 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to Eplontersen in ATTR CM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.